Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pileri

Showing results (881-890 of 992) with videos related to

Pageof 100
Sort By:
Leukemia|July 25, 2021
Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphomaAlessandra Rossi, Stefania Orecchioni, Paolo Falvo, et al.
Blood|July 29, 1998
Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapyP L Zinzani, M Martelli, M Magagnoli, et al.
Haematologica|November 23, 2023
Massive parallel sequencing unveils homologous recombination deficiency in follicular dendritic cell sarcomaLuisa Lorenzi, Torsten Haferlach, Luigi Mori, et al.
Plos One|November 24, 2011
SNPs array karyotyping reveals a novel recurrent 20p13 amplification in primary myelofibrosisGiuseppe Visani, Maria Rosaria Sapienza, Alessandro Isidori, et al.
Blood|January 26, 2008
Novel markers of normal and neoplastic human plasmacytoid dendritic cellsTeresa Marafioti, Jennifer C Paterson, Erica Ballabio, et al.
British Journal of Haematology|September 22, 2005
Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL NetworkMarkus Tiemann, Carsten Schrader, Wolfram Klapper, et al.
The American Journal of Pathology|January 1, 2003
Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulinsStefano A Pileri, Gianluca Gaidano, Pier Luigi Zinzani, et al.
Haematologica|May 15, 2003
High-dose therapy with autologous transplantation for Hodgkin's disease: the Bologna experiencePier Luigi Zinzani, Monica Tani, Annalisa Gabriele, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2010
Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patientsPier Luigi Zinzani, Giuseppe Rossi, Silvia Franceschetti, et al.
Blood|April 9, 1999
ALK+ lymphoma: clinico-pathological findings and outcomeB Falini, S Pileri, P L Zinzani, et al.
Pageof 100

Showing results (881-890 of 992) with videos related to

Sort By:
Pageof 100
Leukemia|July 25, 2021
Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphomaAlessandra Rossi, Stefania Orecchioni, Paolo Falvo, et al.
Blood|July 29, 1998
Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapyP L Zinzani, M Martelli, M Magagnoli, et al.
Haematologica|November 23, 2023
Massive parallel sequencing unveils homologous recombination deficiency in follicular dendritic cell sarcomaLuisa Lorenzi, Torsten Haferlach, Luigi Mori, et al.
Plos One|November 24, 2011
SNPs array karyotyping reveals a novel recurrent 20p13 amplification in primary myelofibrosisGiuseppe Visani, Maria Rosaria Sapienza, Alessandro Isidori, et al.
Blood|January 26, 2008
Novel markers of normal and neoplastic human plasmacytoid dendritic cellsTeresa Marafioti, Jennifer C Paterson, Erica Ballabio, et al.
British Journal of Haematology|September 22, 2005
Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL NetworkMarkus Tiemann, Carsten Schrader, Wolfram Klapper, et al.
The American Journal of Pathology|January 1, 2003
Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulinsStefano A Pileri, Gianluca Gaidano, Pier Luigi Zinzani, et al.
Haematologica|May 15, 2003
High-dose therapy with autologous transplantation for Hodgkin's disease: the Bologna experiencePier Luigi Zinzani, Monica Tani, Annalisa Gabriele, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2010
Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patientsPier Luigi Zinzani, Giuseppe Rossi, Silvia Franceschetti, et al.
Blood|April 9, 1999
ALK+ lymphoma: clinico-pathological findings and outcomeB Falini, S Pileri, P L Zinzani, et al.
Pageof 100